Introduction {#sec1}
============

Lower respiratory tract infection (LRTI) refers to infections of the trachea, bronchus, and lungs, including tracheitis, bronchitis, bronchiolitis, and pneumonia. The most common viral LRTIs among young children are acute bronchiolitis and pneumonia. Acute bronchiolitis is characterized by tachypnea, wheezing, suprasternal or intercostal retraction, sometimes cyanosis or apnea, and even respiratory failure.[@bib1] As a virus-predominant disease, the most common acute bronchiolitis pathogen is respiratory syncytial virus (RSV), causing more than 50% of cases. Other respiratory pathogens include the influenza virus, parainfluenza virus, adenovirus (ADV), rhinovirus, and enterovirus.[@bib2]

Human metapneumovirus (hMPV), human bocavirus (hBoV), and human coronavirus NL-63 (hCoV NL-63) are three of the novel viruses resulting in similar symptoms to RSV, including acute wheezing episodes.[@bib3], [@bib4] Their incidences among children with LRTI vary between 1.5--17.5%,[@bib5] 1.5--11.3%,[@bib6] and 1.3--9.3%,[@bib7], [@bib8] respectively. Detection of these viruses relies on polymerase chain reaction (PCR) in reference laboratories.

Concomitant detection of two or three respiratory viruses in one individual could occur. Bonzel et al.[@bib9] reported a 21% mixed infection rate among children with virus positive acute respiratory infection. The combination of RSV and hBoV accounts for two-thirds of their mixed infections. The occurrence of dual infection is a risk factor of greater disease severity.[@bib10] Evidence also showed that severe viral infection in infancy or early childhood is related to recurrent wheezing and asthma in later life, especially RSV and hMPV infections.[@bib11]

This study explores the epidemiology of viral LRTIs in young children, including single and mixed infections. We also tried to sketch the clinical picture of novel respiratory viruses compared with RSV bronchiolitis.

Methods {#sec2}
=======

Patients {#sec2.1}
--------

The inclusion criteria for this study were: (1) young children aged younger than 36 months; (2) hospitalization at general wards or newborn center of Mackay Memorial Hospital, Taipei from April 1 to December 31, 2007; and (3) a diagnosis of acute bronchiolitis and/or pneumonia. Acute bronchiolitis was defined as acute episodes of cough, rhinorrhea, wheezing or rales, with chest X-ray findings of over aeration, peribronchial infiltration with or without atelectasis. Pneumonia was defined as febrile episodes with rales and chest X-ray findings for airbronchogram or haziness of the lung fields. Fully informed consents were acquired and patients whose parents refused to join this project were excluded.

Specimens {#sec2.2}
---------

We prospectively collected oropharyngeal swabs with sterile cotton buds and nasopharyngeal aspiration (NPA) fluids from all subjects within 48 hours of admission. The specimens were preserved in standard transport media under 4°C refrigeration and were transported to the Department of Clinical Virology and Microbiology Laboratory of our hospital for virus culture, antigen detection, and nucleic acid (NA) amplification. Three to five milliliters of serum was obtained from each subject for complete blood counts and C-reactive protein.

Viral identification {#sec2.3}
--------------------

The oropharyngeal swabs were inoculated on four cell lines (MRC-5 from fibroblast of human fetal lung, Hep-2, A549 from laryngeal carcinoma, and RD cell from rhabdomyosarcoma) for isolation of respiratory viruses. The type of viruses was confirmed by reactions with immunofluorescent antibodies following typical cytopathic effects.

NPA fluid samples were sent for direct immunofluorescence assay to detect RSV (IMAGEN RSV, OXOID, Basingstoke, UK) and Influenza A and B (QuickVue Influenza Test, QUIDEL, San Diego, CA, USA).

The NA amplification method was applied to identify the three novel respiratory viruses. NAs were extracted from 200 μL of NPA fluid with High Pure Viral Nucleic Acid Kit (Roche, Basel, Switzerland) and QIAamp Viral RNA Mini Kit (QIAGEN, Duesseldorf, Germany). For hBoV, PCR was performed with 2 primers of 188 forward (GACCTCTGTAAGTACTATTAC) and 542 reverse (CTCTGTGTTGACTGAATACAG).[@bib12] For hMPV and hCoV NL-63, complementary DNA was synthesized by using 10 μL of eluted RNA and Advantage RT-for-PCR kit (Clontech, Mountain View, CA, USA). PCR for hMPV was performed with two new primers: N1 forward (TCTACAGGCAGCAAAGCAGA) and N1 reverse (TTTGGGCTTTGCCTTAAATG), amplifying a 224-bp region on nucleoprotein (N) gene of hMPV.[@bib13] Nested PCR for hCoV NL-63 was performed with two sets of primers: repSZ-l (GTGATGCATATGCTAATTTG) and repSZ-3 (CTCTTGCAGGTATAATCCTA), repSZ-2 (TTGGTAAACAAAAGATAACT) and repSZ-4 (TGAATGGTATAAACAGTCAT).[@bib14]

Clinical data {#sec2.4}
-------------

The clinical data of concern included demographic data (age, sex, and underlying disease), history (past history of atopic diseases and LRTIs, symptoms and signs contributory to the diagnosis of bronchiolitis and/or pneumonia, vital signs at admission, and duration of fever), in-hospital workup (complete blood counts, C-reactive protein, and chest X-ray), treatment (type and duration of O~2~ support), and outcome (duration of hospitalization and complications). Further development of asthma within 2 years after current illness according to chart review was recorded. Atopic diseases referred to atopic dermatitis, allergic rhinitis, and asthma. Dyspnea was defined as presence of tachypnea, cyanosis, suprasternal, or intercostal retractions. The severity of acute bronchiolitis was rated by a 5-component bronchiolitis clinical score system, modified from Bentur's[@bib15] study in 1992, ranging from 0 to 10 points ([Table 1](#tbl1){ref-type="table"} ). Mild, moderate, and severe acute bronchiolitis were defined as total score of 0--3, 4--7, and 8--10 points, respectively.Table 1Five-component bronchiolitis clinical score system for rating the severity of acute bronchiolitis[@bib15]Score012Duration of hospital stay (d)\<34--7\>8Respiratory supportNilO~2~ tentRespiratorWheezeInspiratory phaseInspiratoy and expiratory phaseDiminishing breath soundsRespiratory rate (/min)20--4040--60\>60DyspneaNasal flaring/subcostal retractionNilYes, without cyanosisYes, with cyanosis

Statistic analysis {#sec2.5}
------------------

All data were expressed with mean ± standard deviation or median with range. Categorical data were analyzed using χ^2^ test or Fisher's exact test. Intervals and ordinal data were analyzed using the Mann-Whitney *U* test. Statistical significance was defined as a *p* value less than 0.05.

Results {#sec3}
=======

A total of 48 children aged 2--32 months (mean 11.6 ± 7.7 months) were enrolled and followed up for at least 2 years (till December, 2009). There were 30 males and 18 females with a male-to-female ratio of 1.6 to 1. The diagnoses were acute bronchiolitis (36 patients, 75%), pneumonia (4 patients, 8.3%) or both (8 patients, 16.7%). Detailed demographic data were showed in [Table 2](#tbl2){ref-type="table"} . All patients achieved full recovery without long-term sequelae. According to the chart review, 13 children had newly diagnosed asthma during the follow-up period.Table 2Demographic data of patients with acute bronchiolitis or pneumoniaPatient, *n* (%)RangeMeanStandard deviationAge (mo)2.1--32.011.67.7Gender (male)30 (62.5)Underlying disease Pulmonary4 Extrapulmonary2Past history Asthma3 Atopy6 Acute bronchiolitis7Duration of hospitalization (d)3--115.22.1Fever37 (77.0) Duration of fever (d)1--203.93.4 Highest temperature (°C)38.0--40.939.21.0Dyspnea33 (68.8) O~2~ support (O~2~ hood)42 (87.5) Duration of O~2~ support (d)1--94.52.2White blood cell counts (1,000/μL)4.7--24.611.44.2 Eosinophil counts (μL)0--1,608170295C-reactive protein (mg/dL)0.01--14.801.893.11Bronchiolitis clinical score0--73.51Complication Croup2 Acute otitis media9 Sinusitis6 Pneumonia12 (25.0) Newly developed asthma[a](#tbl2fna){ref-type="table-fn"}13 (27.1)[^1]

A total of 33 children's specimens underwent both virus culture and PCR procedure. Among them, 11 children had identifiable viruses with virus culture (virus yield rate: 33.3%), whereas an additional 7 children were found to have novel respiratory viruses with PCR methods (overall virus yield rate: 54.5%).

Type of virus {#sec3.1}
-------------

Forty-three respiratory viruses were detected. The two most predominant pathogens were RSV and hMPV ([Fig. 1](#fig1){ref-type="fig"} ). Comparing the clinical data from these two groups, most variables showed no significant difference ([Table 3](#tbl3){ref-type="table"} ), except that mixed infection with other respiratory viruses was more common in the hMPV group (*p* = 0.038). There was a trend toward longer O~2~ demand in RSV-infected children than hMPV-infected ones (*p* = 0.053). No any hCoV NL-63 or influenza virus was identified in our patients.Figure 1.Identified viruses in children with lower respiratory tract infection.Table 3Comparison of clinical data between children with respiratory syncytial virus and human metapneumovirus infectionRSV (*n* = 20)hMPV (*n* = 13)*p*Age (mo)9.2 (2.4--27.7)11.0 (2.1--32.1)0.796Gender Male157 Female560.270Underlying disease01 (ASDII)Past history Asthma221.000 Atopy421.000 Acute bronchiolitis111.000Mixed infection6 (30%)9 (69%)0.038Duration of hospitalization (d)4.5(3--9)4 (2--10)0.267Fever16101.000 Duration of fever (d)4 (1--8)2.5 (1--6)0.412 Highest temperature(°C)39.0 (38.2--40.9)39.6 (38.7--40.0)0.969Dyspnea1680.425 O~2~ support (O~2~ hood)19100.276 Duration of O~2~ support (d)4 (0--9)2 (0--5)0.053Respiratory rate (/min)32 (25--56)30 (22--50)0.454Heart rate (/min)134 (114--156)140 (116--160)0.985White blood cell counts (1,000/μL)9.25 (5.0--18.8)9.4 (4.7--16.6)0.580 Eosinophil counts (μL)36 (0--564)58 (0--332)0.830C-reactive protein (mg/dL)0.52 (0.04--9.01)0.35 (0.01--2.21)0.417Hemoglobin (g/dL)12.0 (10.1--14.1)11.5 (9.2--12.9)0.209Platelet (K/μL)306 (169--495)409 (184--678)0.074Bronchiolitis clinical score4 (2--5)3 (0--5)0.151 Mild (0--4)1411 Moderate (5--8)620.431Associated condition Acute otitis media311.000 Sinusitis311.000 Pneumonia531.000 Newly developed asthma[a](#tbl3fna){ref-type="table-fn"}550.461[^2][^3]

Type of infection {#sec3.2}
-----------------

The numbers of patients with 0, 1, 2, and 3 kinds of viruses identified were 14, 26, 7, and 1, respectively ([Fig. 2](#fig2){ref-type="fig"} ). Mixed infection comprised 23.5% of 34 children with identifiable viruses. The clinical features of patients with single and mixed infection are shown in [Table 4](#tbl4){ref-type="table"} . Dual infections occurred in RSV with hMPV (two patients), hBoV (one patient), or HSV (one patient), as well as in hMPV with hBoV (one patient), ADV (one patient) or parainfluenza virus3 (one patient). One patient had RSV, hMPV, and ADV identified at the same time.Figure 2.Numbers of identified virus in children with lower respiratory tract infection.Table 4Comparison of clinical data between children with single and mixed infectionSingle infection (*n* = 26)Mixed infection (*n* = 8)Age (mo)11.2 (4.1--18.3)13.8(5.1--22.6)Gender Male213 Female55Past history Asthma31 Atopy42 Acute bronchiolitis30Duration of hospitalization (d)5.2 (3.1--7.4)3.8 (2.9--4.6)Fever217 Duration of fever (d)3.4 (1.2--5.6)3.4 (1.9--4.9) Highest temperature (°C)39.2 (38.3--40.0)39.3 (38.9--39.7)Dyspnea204 O~2~ support (O~2~ hood)256 Duration of O~2~ support (d)4.4 (2.1--6.6)2.5 (0.5--4.5)Respiratory rate (/min)37 (26--47)36 (27--44)Heart rate (/min)135 (122--147)132 (122--146)White blood cell counts (1,000/μL)10.4 (6.2--14.5)10.9 (6.8--15.0) Eosinophil counts (/μL)178 (0--498)48 (0--114)C-reactive protein (mg/dL)1.65 (0--4.06)0.82 (0--1.67)Hemoglobin (g/dL)11.8 (10.6--13.0)11.6 (11.0--12.2)Platelet (K/μL)315 (229--402)415 (279--550)Bronchiolitis clinical score3.8 (2.8--4.8)2.6 (0.6--4.6) Mild (0--4)177 Moderate (5--8)91Associated condition Acute otitis media60 Sinusitis40 Pneumonia53 Newly developed asthma[a](#tbl4fna){ref-type="table-fn"}73[^4]

Correlation between LRTI and asthma {#sec3.3}
-----------------------------------

Children with higher bronchiolitis clinical scores had higher chance to have asthma in later life (*p* = 0.042). Its odds ratio for asthma was 4.33 (95% confidence interval = 1.16--16.26). However, the odds ratios of RSV and hMPV infection to asthma in later life were 0.52 (95% confidence interval = 0.15--1.83) and 1.36 (95% confidence interval = 0.36--5.13), respectively.

Discussion {#sec4}
==========

With the development of PCR techniques, novel respiratory viruses are being found, allowing us to better explore the picture of acute respiratory tract infections. So far, PCR-based surveys on the epidemiology of young children LRTIs in Taiwan have been limited.[@bib7], [@bib16], [@bib17] The present study described the incidence, demographic characteristics, and clinical characteristics of LRTIs caused by various viruses. In one recent PCR-based study on children below 2 years old with acute bronchiolitis, the viral isolation rate elevated from 48% to 90% after applying PCR technique in addition to traditional virus culture.[@bib2] Another study enrolled 182 infants hospitalized with acute bronchiolitis showed a rise in virus yield rate from 42.3% to 57.2%.[@bib18] In our study, the virus yield rate was 33.3% with virus culture and 54.5% with additional PCR methods. These results suggest that PCR technique is a promising tool in clinical virology studies, helping researchers to explore viral diseases in a more comprehensive perspective.

As in the previous literature, RSV is always the leading pathogen of acute bronchiolitis. The isolation rate varies with different study designs and geographic areas. Mlinaric-Galinovic et al.[@bib18] reported that RSV was responsible for 49% of 1,010 hospitalized Croatian infants with LRTI and younger than 6 months old over an 11-year period. In the study of Miron et al.[@bib2] in Israel, 490 previously healthy babies younger than 24 months hospitalized for acute bronchiolitis during 4 winter months were enrolled. RSV was identified in 76% of children. Midulla et al.[@bib19] found RSV in 41.2% of 182 Italian infants with acute bronchiolitis in three consecutive annual epidemic periods. In our study, RSV was the most frequently detected virus, presented in 41.7% of all patients. RSV in Taiwan circulates year-round and peaks mainly in spring and fall with annual variation.[@bib20] Thus, if we enrolled patients over 12 months the incidence of RSV may change.

hMPV isolation has been reported around the world since 2001,[@bib21], [@bib22] with various prevalence from 1.5% to 17.5% in children hospitalized with acute respiratory illness. However, hMPV-positive patients accounted for up to 27.1% in our study, which may be related to N gene use with higher sensitivity in hMPV detection. Regarding the difference between RSV and hMPV, Chan et al. reported that RSV-infected children at a younger age lead to longer hospital stays and higher oxygen demand than hMPV did.[@bib23] On the other hand, Viazov reported that the clinical characters of RSV and hMPV bronchiolitis showed no significant difference, except the duration of symptoms was shorter in hMPV-infected patients.[@bib24] Mullins' data showed similar disease severity in RSV and hMPV-infected children.[@bib25] No significant difference was found in hospital stay or fever duration, severity score, white blood cell counts, C-reactive protein, or complication rate in our study, similar to Carraciolo's report.[@bib26] However, RSV-positive patients showed a trend for longer duration of O~2~ demand (*p* = 0.053). The discrepancy among these studies may result from the great heterogenecity in studied populations (age group, diagnosis, and inpatient/outpatient). To differentiate these two viruses judging by clinical information is difficult. Therefore, further researches with large sample sizes and detailed subgroup analyses are necessary.

The prevalence of hBoV varies considerably between 1.5 and 11.3% in children suffering from acute respiratory infections.[@bib6] In addition to LRTIs, it can cause wheezing, respiratory distress, hypoxia, fever, rhinitis, and laryngeal croup in children.[@bib27] A high rate of coinfection with other respiratory viruses (up to 91% in Thailand[@bib6]) makes it difficult to clarify the pathogenic role of hBoV. In the Italian report, hBoV was isolated in 8.2% of patients, including 61.8% of coinfection with various viruses, which resulted in difficulties in defining the true causative virus.[@bib28] Dina et al.[@bib29] reported a 1.6% incidence of hBoV in hospitalized children in France, with coinfection presented in four of seven hBoV-positive children. The prevalence rate of hBoV in our study was 6.25%, and two of the three hBoV-positive patients had more than one pathogen identified (coinfected with RSV and hMPV, respectively). This result suggests that hBoV does circulate in our community.

hCoV NL-63 has been reported to play a role in acute respiratory tract infection in infants and children, with a percentage from 1.3% in Taiwan[@bib7] and up to 9.3% in France.[@bib8] It is more likely to present as croup or acute bronchiolitis,[@bib30] but pharyngitis, rhinitis, otitis, conjunctivitis, and pneumonia are all within its clinical spectrum. The present study failed to identify any one patient with hCoV NL-63, which may result from its relative low incidence and small sample size.

Simultaneous existence of more than one virus in an individual patient has been reported, with a mixed infection rate ranges from 10% to 30% among hospitalized children, mostly RSV-hMPV and RSV-rhinovirus.[@bib9], [@bib19], [@bib26], [@bib31] In the present study, the mixed infection rate was 16.7% (8 of 48 patients). Furthermore, 30% of RSV-positive (6 of 20) and 69% of hMPV-positive (9 of 13) patients had more than one virus identified. The rate of mixed infection is significantly higher in hMPV group (*p* = 0.038). In previous literatures, the frequency of hMPV and RSV coinfection ranges from 0 to 20%.[@bib32] Whether a mixed infection causes more severe disease is still controversial. Some reported that simultaneous infection with RSV and hMPV was related to higher severity,[@bib10] whereas the other did not.[@bib32] We found no significant difference in severity (duration of hospitalization, fever, O~2~ support, and severity score) among RSV, hMPV, and RSV/hMPV groups. A larger population is needed for clarifying the correlation between dual infection and disease severity.

It is reported that severe viral respiratory infections are more likely to have asthma later in childhood.[@bib11] We found that high severity score is a risk factor of asthma with an odds ratio of 4.33. Although limited data were not sufficient to identify the correlation between individual viral pathogen and asthma, it seemed to be certain of the severe LRTIs effect on the development of asthma. Long-term follow-up and expansion to intensive care unit patients are necessary to get more concrete conclusion.

There are a few limitations in our study. The small-sized population lowers the probability of catching statistical difference and precludes detailed subgroup analysis. A relatively short study period impedes observation of seasonality and may affect the distribution of viruses. Because not many influenza infections occurred in Taiwan during the study period, it could explain why we did not detect the influenza virus. The exclusion of outpatients and intensive care unit patients leads to a conclusion applied to a specific range of disease severity.

In conclusion, with limited PCR-based studies on viral respiratory tract infections in Taiwan, the present study pictures viral epidemiology in young hospitalized children with the focus on novel respiratory viruses. RSV is the most common as a single pathogen, followed by hMPV, which had significantly higher rate of coinfection compared with RSV. Otherwise, the clinical characteristics of hMPV do not significantly differ from those of RSV. Mixed infection was noted in 23.5% of patients with identifiable viral pathogens. hBoV does circulate in the population of Northern Taiwan.
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[^1]: Asthma was diagnosed during the follow-up period.

[^2]: ASDII = Atrial septal defect type II; hMPV = human metapneumovirus; RSV = respiratory syncytial virus.

[^3]: Asthma was diagnosed during the follow-up period.

[^4]: Asthma was diagnosed during the follow-up period.
